Citigroup Boosts Unity Biotechnology (NASDAQ:UBX) Price Target to $6.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective boosted by Citigroup from $5.00 to $6.00 in a research report sent to investors on Friday morning, The Fly reports. Several other research firms also recently commented on UBX. Mizuho dropped their price objective on shares of Unity Biotechnology from $12.00 to $6.00 and set […]

Related Keywords

Jan Van Deursen ,Nathaniel Eames David ,Judith Campisi ,Citigroup ,Unity Biotechnology Inc ,Unity Biotechnology Company Profile ,Virtu Financial ,Capital Investment Advisors ,Schonfeld Strategic Advisors ,Unity Biotechnology ,Get Rating ,Sigma Investments ,Street Group ,Daohong Zhou ,South San Francisco ,Unity Biotechnology Daily ,Nasdaq Ubx ,Subx ,Medical ,Boost Price Target ,Citigroup Inc ,